Highlights

  • Nanollose shares declined 3.70% to AUD 0.078 on 1 May 2026, although remains 95% over the past year.
  • Fourth pilot production spin delivered 580kg of Nullarbor fibre, the largest run to date.
  • Process improvements indicate at least a 60% efficiency uplift at laboratory scale.
  • Cash balance increased to AUD 494,000 at 31 March 2026.
  • Net operating cash outflow reduced to AUD 99,000 during the quarter

Nanollose Ltd (ASX:NC6) saw its share price ease by 3.70% to AUD 0.078 on 1 May 2026, despite releasing a quarterly update that outlined continued technical and strategic progress. The stock remains significantly higher over a longer-term period, with gains of approximately 95% over the past year. The recent price movement comes as investors assess developments in the Company’s fibre technology, operational milestones, and financial position.

Nanollose operates as a biomaterials company focused on developing sustainable alternatives to traditional materials using microbial cellulose. Its core offering centres on producing fibres and fabrics without reliance on wood-based inputs, positioning its technology within the broader regenerated cellulosic fibre market. The Company’s flagship product, Nullarbor fibre, remains central to its commercialisation strategy.

Largest Pilot Production Run Completed

A key development during the March quarter was the successful completion of Nanollose’s fourth pilot production spin of Nullarbor fibre. Conducted in collaboration with Birla Cellulose in India, the run produced a total of 580 kilograms of fibre, marking the largest production to date.

The output comprised 425kg of Nullarbor-25 and 155kg of Nullarbor-30 fibre blends, incorporating 25% and 30% microbial cellulose respectively. The balance consisted of FSC-certified wood pulp.

Importantly, the pilot demonstrated that microbial cellulose could be integrated directly into existing lyocell production infrastructure without requiring additional pre-processing. This outcome supports the compatibility of the Company’s feedstock within established Manufacturing systems.

Process Improvements Deliver Efficiency Gains

Following the completion of the fourth pilot spin, Nanollose undertook further development work at the laboratory scale. This resulted in process improvements that are estimated to deliver at least a 60% increase in efficiency compared to the method used during the pilot run.

These improvements are expected to enhance production Economics while also contributing to product consistency. The Company indicated that the refined process involves fewer stages and reduced input requirements, potentially simplifying Manufacturing pathways.

The next phase of work is focused on scaling these improvements, including testing dissolution and spinnability characteristics and identifying suitable equipment for industrial application.

Equipment Trials and Scale-Up Activities Underway

To support scale-up objectives, Nanollose has commenced equipment evaluation trials internationally. These trials are aimed at identifying suitable solutions for key production stages, particularly drying and dewatering of microbial cellulose.

The Company noted that recent process developments have shifted the technical focus toward equipment optimisation rather than fundamental material challenges. Initial results from these trials are expected in the near term.

In addition, post-quarter developments included progress toward establishing a dedicated microbial cellulose processing Facility. Early-stage equipment trials have been completed, and a global tender process for remaining components is underway.

Commercial Pathway Advances Through Partner Engagement

Nanollose also progressed Downstream commercialisation activities during the quarter. Fibres produced from the fourth pilot run are being shipped to Paradise Textiles, part of the Alpine Group, for conversion into yarns and fabrics.

These materials are expected to be distributed to development partners and potential customers for testing and evaluation. The Company continues to engage with Manufacturing and development partners to explore commercial pathways and scale-up opportunities.

This approach aligns with a broader strategy to position the Company as a partner to established industry participants, focusing on integration rather than replacement of existing systems.

Strategic Focus Refined Around Nullarbor Fibre

During the quarter, Nanollose refined its strategic priorities, placing a clear emphasis on Nullarbor fibre as its primary commercial pathway. This decision reflects a focus on allocating resources toward scaling a single core product rather than pursuing multiple opportunities simultaneously.

The Company is targeting the regenerated cellulosic fibre market, which it estimates at approximately US$20 billion. Its technology is designed to complement existing industry infrastructure, allowing manufacturers to incorporate microbial cellulose into current production processes.

A key objective is the development of a dedicated processing line capable of producing sufficient volumes of microbial cellulose pulp to support multi-tonne fibre output per month. This capacity is expected to underpin future commercial agreements.

Cash Position Strengthened by R&D Rebate and Funding

From a financial perspective, Nanollose reported a cash balance of AUD 494,000 at the end of the March quarter, an increase from AUD 272,000 in the previous quarter.

The improvement was supported by a AUD 311,000 Research and Development Tax Incentive rebate received during the period. This rebate contributed to a reduction in net operating cash outflows, which totalled AUD 99,000 for the quarter, compared to cash outflow of AUD 519,000 in the prior quarter.

Operating expenditures included:
• Research and Development costs of AUD 242,000
• Administration and corporate costs of AUD 100,000
• Staff costs of AUD 48,000
• Advertising and Marketing expenses of AUD 18,000

In addition, the Company received AUD 521,000 in Equity proceeds during the quarter and repaid a AUD 200,000 short-term borrowing.

Subsequent to the quarter end, Nanollose secured an additional AUD 423,000 through option conversions, providing further financial flexibility.

Intellectual Property Portfolio Supports Commercial Strategy

Nanollose continues to maintain an intellectual property portfolio comprising 15 granted patents and 8 registered trademarks. These Assets span multiple jurisdictions and support the Company’s licensing and commercialisation strategy.

Recent developments include Patent filings and grants in several regions, reinforcing the Company’s position within the biomaterials space.

Board Update and Organisational Review

During the quarter, a Non-Executive Director stepped down from the Board, with the change taking effect from 1 April 2026. The Company is reviewing its board composition to ensure alignment with its evolving commercial objectives and technical focus.

What This Means for Investors?

The share price decline on 1 May 2026 comes despite a quarterly update that outlined continued technical progress, operational milestones, and improved financial metrics. Investors appear to be weighing these developments alongside broader considerations, including the pace of commercialisation and funding requirements.

The update highlights progress in fibre production, efficiency improvements, and scale-up initiatives, while also demonstrating strengthened Cash Flow dynamics during the quarter. The Company’s focus on advancing its flagship product and establishing production capability remains central to its ongoing strategy.